Overall, LY3009120 acted in a dose-dependent and time-dependent manner in all RAF/RAS mutant and wild-type cell lines, invariably decreasing to varying degrees, except for liver metastasis equine melanoma cells eRGO6. The gene discussed is RAF1; the disease is melanoma.